Elicio Therapeutics
Transforming the lives of patients and their families by re-engineering the body’s immune response to cancer. Learn more
Launch date
Employees
Market cap
$45.1m
Enterprise valuation
$48m (Public information from Sep 2024)
Share price
$5.07 ELTX
Cambridge Massachusetts (HQ)
Authorizing premium user...